Continental Advisors’s Pfizer PFE Stock Holding History

Continental Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.9M	Sell	386,438 -14,500	-4%	-$386K	5.54%	4
2025 Q4	$9.98M	Sell	400,938 -8,000	-2%	-$202K	4.22%	4
2025 Q3	$10.4M	Buy	408,938 +41,600	+11%	+$1.03M	4.51%	2
2025 Q2	$8.9M	Sell	367,338 -58,000	-14%	-$1.35M	4.17%	3
2025 Q1	$10.8M	Buy	425,338 +154,000	+57%	+$4.03M	6.03%	4
2024 Q4	$7.2M	Buy	271,338 +10,900	+4%	+$296K	3.31%	9
2024 Q3	$7.54M	Sell	260,438 -22,754	-8%	-$664K	3.63%	8
2024 Q2	$7.92M	Sell	283,192 -59,000	-17%	-$1.62M	3.48%	6
2024 Q1	$9.5M	Buy	342,192 +134,400	+65%	+$3.73M	3.84%	4
2023 Q4	$5.98M	Sell	207,792 -42,500	-17%	-$1.28M	2.33%	10
2023 Q3	$8.3M	Buy	250,292 +55,600	+29%	+$1.97M	4.42%	5
2023 Q2	$7.14M	Buy	194,692 +32,800	+20%	+$1.28M	3.23%	6
2023 Q1	$6.61M	Buy	161,892 +39,254	+32%	+$1.7M	3.53%	7
2022 Q4	$6.28M	Sell	122,638 -26,964	-18%	-$1.29M	3.29%	9
2022 Q3	$6.55M	Hold	149,602	–	–	3.86%	4
2022 Q2	$7.84M	Sell	149,602 -4,000	-3%	-$204K	4.73%	3
2022 Q1	$7.95M	Buy	153,602 +60,000	+64%	+$3.11M	3.92%	4
2021 Q4	$5.53M	Sell	93,602 -9,900	-10%	-$491K	2.33%	8
2021 Q3	$4.45M	Sell	103,502 -42,100	-29%	-$1.87M	1.89%	21
2021 Q2	$5.7M	Sell	145,602 -15,000	-9%	-$583K	2.63%	13
2021 Q1	$5.82M	Buy	160,602 +54,000	+51%	+$1.92M	2.7%	9
2020 Q4	$3.92M	Sell	106,602 -487	-0.5%	-$17.9K	1.79%	15
2020 Q3	$3.73M	Buy	107,089 +3,162	+3%	+$111K	1.98%	10
2020 Q2	$3.22M	Buy	103,927 +6,324	+6%	+$215K	1.72%	16
2020 Q1	$3.02M	Buy	97,603 +2,108	+2%	+$71.8K	2.25%	9
2019 Q4	$3.55M	Sell	95,495 -11,802	-11%	-$420K	1.71%	15
2019 Q3	$3.66M	Buy	107,297 +7,905	+8%	+$287K	2.16%	12
2019 Q2	$4.08M	Hold	99,392	–	–	2.31%	9
2019 Q1	$4M	Sell	99,392 -86,640	-47%	-$3.47M	1.86%	17
2018 Q4	$7.7M	Sell	186,032 -10,540	-5%	-$438K	2.35%	6
2018 Q3	$8.22M	Sell	196,572 -21,185	-10%	-$816K	1.8%	11
2018 Q2	$7.5M	Hold	217,757	–	–	1.87%	13
2018 Q1	$7.33M	Sell	217,757 -5,270	-2%	-$181K	1.86%	14
2017 Q4	$7.66M	Sell	223,027 -17,918	-7%	-$611K	1.66%	13
2017 Q3	$8.16M	Hold	240,945	–	–	1.87%	12
2017 Q2	$7.68M	Hold	240,945	–	–	1.73%	12
2017 Q1	$7.82M	Hold	240,945	–	–	1.75%	13
2016 Q4	$7.42M	Sell	240,945 -39,525	-14%	-$1.21M	2.02%	8
2016 Q3	$9.01M	Buy	280,470 +41,089	+17%	+$1.37M	2.52%	4
2016 Q2	$8M	Hold	239,381	–	–	2.47%	6
2016 Q1	$6.73M	Sell	239,381 -5,270	-2%	-$151K	1.91%	12
2015 Q4	$7.49M	Sell	244,651 -12,965	-5%	-$408K	1.9%	11
2015 Q3	$7.68M	Hold	257,616	–	–	2.06%	5
2015 Q2	$8.2M	Buy	257,616 +28,985	+13%	+$945K	2.18%	5
2015 Q1	$7.55M	Buy	228,631 +13,281	+6%	+$422K	1.66%	10
2014 Q4	$6.36M	Buy	215,350 +10,540	+5%	+$302K	1.29%	14
2014 Q3	$5.75M	Hold	204,810	–	–	1.31%	14
2014 Q2	$5.77M	Sell	204,810 -10,540	-5%	-$300K	1.34%	14
2014 Q1	$6.56M	Sell	215,350 -1,581	-0.7%	-$47.1K	1.7%	11
2013 Q4	$6.3M	Sell	216,931 -15,810	-7%	-$460K	1.37%	16
2013 Q3	$6.34M	Hold	232,741	–	–	1.57%	13
2013 Q2	$6.18M	Buy	+232,741	New	+$6.43M	1.74%	13

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Continental Advisors's PFE Position: Q1 2026 in Review

Continental Advisors reduced its Pfizer (PFE) stake by 3.6% in Q1 2026, selling an estimated $386K and leaving 386,438 shares worth $10.9M. The position accounts for 5.54% of the portfolio, ranked #4.

Continental Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Continental Advisors held 386,438 shares of Pfizer worth $10.9M as of Q1 2026.
Continental Advisors sold 14,500 Pfizer shares in Q1 2026, an estimated $386K.
Pfizer made up 5.54% of Continental Advisors's portfolio in Q1 2026, its #4 holding.
Continental Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Continental Advisors's 13F filing for Q1 2026, filed 15 May 2026.